Miguel-Angel Perales Selected Research

Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)

11/2023	Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy.
1/2023	ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma.
1/2022	Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
1/2022	ASTCT Committee on Practice Guidelines Survey on Evaluation & Management of Diffuse Large B-cell Lymphoma after Failure of Chimeric Antigen Receptor T Cell Therapy (CAR-T) Therapy.
1/2021	Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells.
1/2021	The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy.
1/2020	CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overview.
1/2020	Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma.
1/2020	Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management.
1/2020	Modern management of relapsed and refractory aggressive B-cell lymphoma: A perspective on the current treatment landscape and patient selection for CAR T-cell therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miguel-Angel Perales Research Topics

Disease

65	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2024 - 09/2006
50	Neoplasms (Cancer) 05/2024 - 01/2002
35	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 02/2007
30	Infections 03/2024 - 09/2006
30	Lymphoma (Lymphomas) 02/2024 - 08/2012
29	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 04/2019
23	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 02/2007
19	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2024 - 02/2013
19	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2023 - 08/2012
18	Leukemia 01/2024 - 02/2007
17	Multiple Myeloma 04/2024 - 07/2015
16	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2023 - 02/2007
14	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2023 - 10/2015
13	COVID-19 01/2024 - 01/2020
13	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 07/2009
9	Cytokine Release Syndrome 05/2024 - 01/2020
7	Viremia 01/2023 - 10/2011
7	Melanoma (Melanoma, Malignant) 01/2013 - 01/2002
6	Cytopenia 04/2024 - 01/2019
6	Bronchiolitis Obliterans Syndrome 02/2024 - 10/2006
6	cell-associated neurotoxicity 01/2023 - 01/2020
5	Communicable Diseases (Infectious Diseases) 03/2024 - 01/2002
5	Neutropenia 11/2023 - 10/2011
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2023 - 02/2014
5	Cytomegalovirus Infections (Inclusion Disease) 12/2022 - 01/2016
3	Inflammation (Inflammations) 04/2024 - 10/2022
3	Thrombocytopenia (Thrombopenia) 01/2023 - 01/2019
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 12/2016
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2019 - 10/2015
2	Thrombotic Microangiopathies 03/2024 - 01/2023
2	Diphtheria 02/2024 - 01/2018
2	Tetanus 02/2024 - 01/2018
2	Whooping Cough (Pertussis) 02/2024 - 01/2018
2	Agammaglobulinemia (Hypogammaglobulinemia) 12/2023 - 10/2023
2	Mycoses (Diseases, Fungus) 09/2023 - 10/2021
2	Hypertension (High Blood Pressure) 06/2023 - 01/2023
2	Clostridium Infections 01/2023 - 01/2017
2	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 01/2022
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2023 - 01/2022
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2022 - 11/2015
2	Invasive Fungal Infections 10/2021 - 01/2020
2	Stomatitis 10/2021 - 11/2013
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

49	Chimeric Antigen ReceptorsIBA 05/2024 - 01/2016
21	axicabtagene ciloleucelIBA 04/2024 - 04/2019
19	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 08/2015
13	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2002
13	tisagenlecleucelIBA 01/2023 - 04/2019
11	Calcineurin InhibitorsIBA 10/2023 - 06/2014
9	VaccinesIBA 02/2024 - 01/2002
9	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2022 - 12/2007
8	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2020
8	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 02/2007
7	Tacrolimus (Prograf)FDA LinkGeneric 06/2023 - 02/2007
7	AntigensIBA 01/2021 - 01/2002
6	Antiviral Agents (Antivirals)IBA 10/2023 - 01/2019
6	Methotrexate (Mexate)FDA LinkGeneric 06/2023 - 02/2007
6	fludarabineIBA 01/2023 - 12/2014
5	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2023 - 03/2014
5	Rituximab (Mabthera)FDA Link 01/2023 - 10/2006
5	Monoclonal AntibodiesIBA 01/2022 - 01/2017
4	Sirolimus (Rapamycin)FDA Link 03/2024 - 03/2014
4	Immunoglobulin G (IgG)IBA 01/2024 - 09/2006
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 03/2016
4	Busulfan (Busulfex)FDA Link 01/2020 - 02/2007
4	DNA VaccinesIBA 01/2013 - 01/2002
4	AutoantigensIBA 01/2013 - 04/2004
4	Monophenol Monooxygenase (Tyrosinase)IBA 12/2008 - 04/2004
3	letermovirIBA 12/2023 - 01/2021
3	Proteasome InhibitorsIBA 10/2023 - 01/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 11/2013
3	CytokinesIBA 01/2022 - 09/2006
3	Voriconazole (Vfend)FDA LinkGeneric 10/2021 - 08/2018
3	Core Binding Factors (Core-Binding Factor)IBA 01/2021 - 01/2018
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 03/2014
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2008 - 01/2002
3	Proteins (Proteins, Gene)FDA Link 05/2006 - 04/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2024 - 02/2009
2	Heme (Haem)IBA 03/2024 - 10/2023
2	Cell-Free Nucleic AcidsIBA 03/2024 - 11/2023
2	trans-crotonin (CTN)IBA 03/2024 - 01/2022
2	terminaseIBA 12/2023 - 01/2021
2	B-Cell Maturation AntigenIBA 10/2023 - 11/2020
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2023 - 01/2016
2	isavuconazoleIBA 10/2021 - 01/2020
2	Fibroblast Growth Factor 7 FDA Link 10/2021 - 11/2013
2	Interleukin-15 (Interleukin 15)IBA 09/2021 - 09/2006
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2017

Therapy/Procedure

89	Cell Transplantation 03/2024 - 02/2014
86	Therapeutics 05/2024 - 01/2002
68	Transplantation 03/2024 - 02/2007
35	Hematopoietic Stem Cell Transplantation 11/2023 - 09/2006
24	Stem Cell Transplantation 07/2023 - 09/2006
16	Drug Therapy (Chemotherapy) 12/2023 - 02/2012
7	Immunotherapy 01/2021 - 01/2002
5	Salvage Therapy 05/2024 - 03/2015
5	Homologous Transplantation 01/2023 - 02/2007
4	Autologous Transplantation 05/2019 - 08/2012
3	Haploidentical Transplantation 01/2022 - 01/2018
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 11/2021